U. Speck

发表

Intrathecal Corticoids in Permanent Focal Cerebral Ischemia in Rats. Part I: A New Therapeutic Approach in the Acute Phase

M. Ladd, S. Maderwald, M. Forsting, 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[Pharmacokinetics and metabolite spectrum of glisoxepide in humans].

W. Mützel, U. Speck, K. Kolb, 1974, Arzneimittel-Forschung.

Pharmacokinetics and Biotransformation of Iohexol in the Rat and the Dog

W. Mützel, U. Speck, 1980, Acta radiologica. Supplementum.

Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.

M. Hümpel, H. Wendt, G. Pommerenke, 1978, Contraception.

Pharmacochemical Profile of lopromide

U. Speck, W. Muetzel, 2013 .

Nonionic dimer: development and initial testing of an intrathecal contrast agent.

R. Ranganathan, M. Sovák, U. Speck, 1982, Radiology.

Procede de diagnostic in vivo par rayons infrarouges proches

W. Semmler, K. Licha, B. Riefke, 1995 .

Sterile composition comprising a chelate complex for magnetic resonance imaging

G. Hoyer, H. Weinmann, U. Speck, 1997 .

[Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].

M. Amin, U. Speck, V. U. Täuber, 1976, Arzneimittel-Forschung.

Intraindividual comparison of pharmacokinetic parameters of d-norgestrel, lynestrenol and cyproterone acetate in 6 women

M. Hümpel, H. Wendt, U. Speck, 1977 .

Bioavailability and pharmacokinetics of cyproterone acetate after oral administration of 2.0 mg cyproterone acetate in combination with 50 micrograms ethinyloestradiol to 6 young women.

M. Hümpel, H. Wendt, U. Speck, 1977, Contraception.

Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB).

H. Wendt, D. Jentsch, U. Speck, 1976, Contraception.

[Bioavailability and pharmacokinetics of 14C-cyproterone acetate after administration as a 50-mg tablet (author's transl)].

H. Wendt, G. Kühne, D. Jentsch, 1976, Arzneimittel-Forschung.

Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys☆

M. Hümpel, B. Düsterberg, U. Speck, 1981 .

Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women.

M. Hümpel, B. Nieuweboer, H. Wendt, 1979, Contraception.

A new principle of injectable depot contraceptives. I Drug selection and studies in monkeys.

M. Hümpel, U. Speck, P. Schulze, 1979, Contraception.

Injectable depot contraceptives on d-norgestrel basis. I. Pharmacokinetic studies in dog and baboons.

M. Hümpel, G. Kühne, U. Speck, 1977, Contraception.

Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.

M. Hümpel, B. Düsterberg, U. Speck, 1979, Contraception.

Bio-availability and pharmacokinetics of cyproterone acetate-carbon-14 and ethinyloestradiol-tritium after oral administration as a coated tablet (SHB 209 AB).

H. Wendt, D. Jentsch, U. Speck, 1976 .

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.

H. Weinmann, W. Press, G. Schuhmann-Giampieri, 1992, Radiology.

Pharmacochemical profile of iopromide.

U. Speck, W. Muetzel, 1983, AJNR. American journal of neuroradiology.